With a $1 billion public commitment, diverse talent and science, space, and VC funding, NYC is emerging as a global capital of life sciences
Brand Insights - Thought Leadership / Paid Program | New York City Economic Development Corporation
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Lupin Invests $250 Million in New Coral Springs Manufacturing Facility to Bolster US Respiratory Drug Supply
2
Pharma Pulse: Mark Cuban Disrupts Drug Pricing, AstraZeneca Expands US Manufacturing, and BMS Bets Big on RNA Therapeutics
3
